Author:
Breitz Hazel B.,Fritzberg Alan R.
Reference224 articles.
1. Abdel-Nabi HH,Spaulding M,Farrell E,Derby L, Lamonica D. Treatment of refractory prostate carcinoma with Y90 KC4. J Nucl Med (Suppl.) 1995; 36: 213 P.
2. Adelstein SJ, Kassis AI. Radiobiologic implications of the microscopic distribution of energy from radionuclides. Nucl Med Biol 1987; 14: 165–9.
3. Aljouni MI,Merrick H, Skeel RT, Dobeelbower RR. Concomitant radiation therapy and constant infusion FudR for unresectable liver metastases. Am J Clin Oncol 1990; 13: 532–5.
4. Alvarez RD,Partridge EE, Khazaeli MB et al. Intraperitoneal radioimmunotherapy of ovarian cancer with 177LuCC49: a phase I/II study. Gynecol Oncol 1997; 65: 94–101.
5. Appelbaum FR,Matthews DC, Eary JF et al. Use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia. Transplantation 1992; 54: 829–33.